Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytodiagnosis | 5 | 2022 | 419 | 2.850 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2022 | 294 | 1.990 |
Why?
|
| Azo Compounds | 3 | 2022 | 123 | 1.860 |
Why?
|
| Laboratories | 3 | 2022 | 444 | 1.540 |
Why?
|
| Staining and Labeling | 4 | 2022 | 1143 | 1.420 |
Why?
|
| Pathology, Clinical | 3 | 2022 | 368 | 1.410 |
Why?
|
| Breast | 6 | 2021 | 1819 | 1.390 |
Why?
|
| Macrophages, Alveolar | 2 | 2022 | 437 | 1.370 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 841 | 1.280 |
Why?
|
| Placenta Diseases | 3 | 2022 | 188 | 1.040 |
Why?
|
| Lung Transplantation | 3 | 2022 | 1163 | 0.990 |
Why?
|
| Cephapirin | 1 | 2022 | 3 | 0.950 |
Why?
|
| Adenolymphoma | 1 | 2022 | 10 | 0.920 |
Why?
|
| Nocardia | 1 | 2021 | 12 | 0.890 |
Why?
|
| Nocardia Infections | 1 | 2021 | 21 | 0.890 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2021 | 100 | 0.810 |
Why?
|
| Cell Biology | 1 | 2021 | 92 | 0.800 |
Why?
|
| Amylases | 1 | 2020 | 186 | 0.800 |
Why?
|
| Oxyphil Cells | 1 | 2020 | 45 | 0.800 |
Why?
|
| Pregnancy, High-Risk | 1 | 2020 | 110 | 0.780 |
Why?
|
| Foam Cells | 1 | 2020 | 75 | 0.770 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2021 | 106 | 0.770 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 75 | 0.770 |
Why?
|
| Uterine Cervical Diseases | 1 | 2020 | 79 | 0.760 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 307 | 0.720 |
Why?
|
| Pleural Effusion | 1 | 2021 | 340 | 0.700 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2021 | 1973 | 0.690 |
Why?
|
| Mediastinal Diseases | 1 | 2018 | 94 | 0.660 |
Why?
|
| Sex Reassignment Surgery | 2 | 2020 | 89 | 0.650 |
Why?
|
| Coloring Agents | 1 | 2020 | 550 | 0.650 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2017 | 69 | 0.650 |
Why?
|
| Maternal Age | 1 | 2020 | 792 | 0.630 |
Why?
|
| Cholangitis | 1 | 2017 | 107 | 0.610 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2017 | 286 | 0.590 |
Why?
|
| Cervix Uteri | 1 | 2020 | 578 | 0.580 |
Why?
|
| Tyrosine | 1 | 2020 | 1505 | 0.580 |
Why?
|
| Specimen Handling | 1 | 2021 | 696 | 0.580 |
Why?
|
| Pelvis | 1 | 2020 | 697 | 0.580 |
Why?
|
| Granuloma | 1 | 2018 | 330 | 0.580 |
Why?
|
| Sweat Glands | 1 | 2015 | 32 | 0.570 |
Why?
|
| Cytological Techniques | 3 | 2022 | 214 | 0.570 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2020 | 790 | 0.570 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 2033 | 0.560 |
Why?
|
| Hyoid Bone | 1 | 2015 | 40 | 0.560 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 944 | 0.560 |
Why?
|
| Scalp Dermatoses | 1 | 2015 | 52 | 0.550 |
Why?
|
| Epidermal Cyst | 1 | 2015 | 66 | 0.550 |
Why?
|
| Neurocysticercosis | 1 | 2015 | 39 | 0.550 |
Why?
|
| Placenta | 2 | 2021 | 1534 | 0.540 |
Why?
|
| Osteochondroma | 1 | 2015 | 44 | 0.540 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 516 | 0.540 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 919 | 0.510 |
Why?
|
| Checklist | 1 | 2021 | 790 | 0.500 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2021 | 1106 | 0.490 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2021 | 1059 | 0.470 |
Why?
|
| Lymph Nodes | 3 | 2020 | 3424 | 0.460 |
Why?
|
| Leadership | 1 | 2022 | 1345 | 0.460 |
Why?
|
| Calcinosis | 1 | 2020 | 1453 | 0.430 |
Why?
|
| Epithelium | 1 | 2017 | 1720 | 0.430 |
Why?
|
| Quality Assurance, Health Care | 1 | 2022 | 2260 | 0.410 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1991 | 0.410 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2021 | 115 | 0.400 |
Why?
|
| Biopsy | 5 | 2022 | 6732 | 0.360 |
Why?
|
| Neoplasms | 3 | 2021 | 20515 | 0.340 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 13215 | 0.330 |
Why?
|
| Electronic Health Records | 2 | 2021 | 4276 | 0.320 |
Why?
|
| Calcium | 1 | 2020 | 5793 | 0.310 |
Why?
|
| Macrophages | 1 | 2022 | 5746 | 0.310 |
Why?
|
| Low Back Pain | 1 | 2015 | 933 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 3991 | 0.300 |
Why?
|
| Humans | 39 | 2022 | 715594 | 0.290 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 20066 | 0.240 |
Why?
|
| Mediastinum | 3 | 2020 | 263 | 0.240 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2576 | 0.220 |
Why?
|
| Retrospective Studies | 11 | 2022 | 72448 | 0.220 |
Why?
|
| Female | 23 | 2022 | 377052 | 0.210 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2022 | 105 | 0.210 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10600 | 0.210 |
Why?
|
| Pathology, Surgical | 1 | 2022 | 149 | 0.210 |
Why?
|
| Salivary Glands | 1 | 2022 | 234 | 0.200 |
Why?
|
| Trophoblasts | 1 | 2021 | 216 | 0.190 |
Why?
|
| Fetal Death | 1 | 2021 | 456 | 0.190 |
Why?
|
| Middle Aged | 13 | 2022 | 214639 | 0.180 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 322 | 0.170 |
Why?
|
| Endosonography | 2 | 2019 | 573 | 0.160 |
Why?
|
| Diagnostic Errors | 2 | 2022 | 1268 | 0.160 |
Why?
|
| Retinal Dehydrogenase | 1 | 2017 | 73 | 0.160 |
Why?
|
| Adult | 12 | 2021 | 212237 | 0.160 |
Why?
|
| Fungi | 1 | 2020 | 327 | 0.160 |
Why?
|
| Breast Diseases | 1 | 2020 | 446 | 0.150 |
Why?
|
| Hematoma | 1 | 2022 | 744 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15185 | 0.150 |
Why?
|
| Benchmarking | 1 | 2022 | 927 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 867 | 0.150 |
Why?
|
| Cartilage | 1 | 2019 | 806 | 0.130 |
Why?
|
| Airway Obstruction | 1 | 2020 | 649 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 620 | 0.130 |
Why?
|
| Nanomedicine | 1 | 2017 | 293 | 0.130 |
Why?
|
| Sensation Disorders | 1 | 2015 | 159 | 0.130 |
Why?
|
| Observer Variation | 1 | 2020 | 2671 | 0.120 |
Why?
|
| Young Adult | 5 | 2020 | 56140 | 0.120 |
Why?
|
| Aged | 7 | 2021 | 162392 | 0.120 |
Why?
|
| Lumbosacral Region | 1 | 2015 | 311 | 0.120 |
Why?
|
| Pregnancy | 4 | 2022 | 27362 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2967 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 1192 | 0.120 |
Why?
|
| Androgens | 1 | 2020 | 1231 | 0.120 |
Why?
|
| Scalp | 1 | 2015 | 381 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2015 | 407 | 0.110 |
Why?
|
| Microscopy | 1 | 2017 | 860 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2017 | 1799 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1894 | 0.110 |
Why?
|
| Adolescent | 4 | 2020 | 85064 | 0.100 |
Why?
|
| Male | 11 | 2022 | 350143 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2022 | 11664 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3247 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 58293 | 0.100 |
Why?
|
| Mastectomy | 1 | 2018 | 1703 | 0.100 |
Why?
|
| Spinal Diseases | 1 | 2015 | 552 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2326 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2017 | 846 | 0.090 |
Why?
|
| Testosterone | 1 | 2020 | 2361 | 0.090 |
Why?
|
| Stillbirth | 2 | 2022 | 314 | 0.090 |
Why?
|
| Mammaplasty | 1 | 2018 | 1127 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 1371 | 0.090 |
Why?
|
| Bacteria | 1 | 2020 | 2113 | 0.090 |
Why?
|
| Prognosis | 2 | 2020 | 28991 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2309 | 0.080 |
Why?
|
| Thrombosis | 1 | 2022 | 2842 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 1336 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2019 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11139 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2020 | 41184 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3816 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4490 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2020 | 3264 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 5914 | 0.060 |
Why?
|
| Sepsis | 1 | 2017 | 2463 | 0.060 |
Why?
|
| Incidence | 1 | 2022 | 20761 | 0.060 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2033 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7445 | 0.060 |
Why?
|
| Lung | 1 | 2022 | 9734 | 0.060 |
Why?
|
| United States | 2 | 2021 | 67895 | 0.060 |
Why?
|
| Child | 2 | 2020 | 74413 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8560 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8996 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39334 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13219 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 34561 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 51354 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11644 | 0.040 |
Why?
|
| Nephrosis, Lipoid | 1 | 2017 | 50 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 40040 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2017 | 210 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 431 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 12530 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2017 | 23482 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 819 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 40889 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 34429 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1323 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 1916 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 1119 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1440 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 1554 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 2644 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 2787 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 70931 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1474 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3800 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5859 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 2172 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3631 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 62039 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4388 | 0.020 |
Why?
|
| Communication | 1 | 2022 | 3501 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 169173 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6631 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2018 | 2121 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 6855 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 24776 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9494 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16726 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 80270 | 0.010 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_